EnerSys to Acquire Ultralife for $320M Cash; Q2 Order Bookings Rise 21%
Read source articleWhat happened
On November 18, 2026, EnerSys announced a definitive agreement to acquire Ultralife Corporation for $320 million in cash, expanding its specialty and defense battery portfolio. The company also reported that total second-quarter order bookings increased 21% year over year, driven by strong demand in Energy Systems and Specialty segments. The acquisition follows the 2024 Bren-Tronics deal and signals continued M&A under new CEO Shawn O'Connell, aiming to bolster higher-margin military and medical markets. However, the transaction will consume cash and likely increase net leverage, adding integration risk at a time when EnerSys is already executing a major restructuring and the Greenville gigafactory. The order growth is encouraging but must be weighed against soft Motive Power volumes and the company's heavy reliance on IRA Section 45X tax credits.
Implication
Investors should monitor whether Ultralife adds accretive growth and margin without stretching the balance sheet; net leverage will rise, so watch post-deal net debt/EBITDA. The 21% order growth, if sustained and converting to revenue, supports the bull case but does not eliminate concentration risk in Energy Systems. However, the acquisition adds integration complexity and further cash outflows, potentially reducing share buybacks. The core thesis remains that the stock is fully valued at 18x earnings with dependence on 45X credits; the acquisition does not change that view. A pullback toward $135 would offer a more attractive entry.
Thesis delta
The acquisition reinforces the strategic pivot toward specialty/defense, consistent with the prior Bren-Tronics move, but adds execution risk and uses cash. It does not materially change the core revenue growth or margin outlook; the stock's valuation remains stretched. The order growth is positive but largely expected given AI/grid demand; we maintain a cautious stance.
Confidence
medium